.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Julphar
Novartis
Farmers Insurance
Baxter
Cipla
Colorcon
US Department of Justice
US Army
Fuji

Generated: July 21, 2017

DrugPatentWatch Database Preview

CODRIX Drug Profile

« Back to Dashboard

Which patents cover Codrix, and what generic Codrix alternatives are available?

Codrix is a drug marketed by Watson Labs Florida and is included in three NDAs.

The generic ingredient in CODRIX is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

Summary for Tradename: CODRIX

Patents:0
Applicants:1
NDAs:3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CODRIX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Florida
CODRIX
acetaminophen; codeine phosphate
TABLET;ORAL040441-001Mar 27, 2003DISCNNoNo► Subscribe► Subscribe
Watson Labs Florida
CODRIX
acetaminophen; codeine phosphate
TABLET;ORAL040447-001Feb 26, 2003DISCNNoNo► Subscribe► Subscribe
Watson Labs Florida
CODRIX
acetaminophen; codeine phosphate
TABLET;ORAL040488-001Mar 28, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Dow
Merck
Johnson and Johnson
McKinsey
Federal Trade Commission
US Army
Baxter
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot